Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 36

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 36
---
 penalties, administrative and enforcement actions and litigation,
any of which could harm their business and reputation. Likewise, Renovaro Cube and BioSymetrics rely on third-party research institution
collaborators and other third parties to conduct clinical validation, and similar events relating to their computer systems could also
have a material adverse effect on Renovaro Cube’s or BioSymetrics’ business. To the extent that any disruption or security
breach were to result in a loss of, or damage to, Renovaro Cube’s or BioSymetrics’ data or systems, or inappropriate or unauthorized
access to or disclosure or use of confidential, proprietary, or other sensitive, personal, or health information, Renovaro Cube or BioSymetrics
could incur liability and suffer reputational harm, and the development and commercialization of its products could be delayed.

Renovaro
Cube’s or BioSymetrics’ insurance policies may not be adequate to compensate it for the potential losses arising from such
disruptions, failure, or security breach. In addition, such insurance may not be available to Renovaro Cube or BioSymetrics in the future
on economically reasonable terms, or at all. Further, Renovaro Cube’s or BioSymetrics’ insurance may not cover all claims
made against it and defending a suit, regardless of its merit, could be costly, divert management attention and harm Renovaro Cube’s
or BioSymetrics’ reputation.

If
Renovaro Cube or BioSymetrics is unable to protect the confidentiality of its trade secrets, Renovaro Cube’s or BioSymetrics’
business and competitive position would be harmed.

Renovaro
Cube and BioSymetrics rely on trade secrets and confidentiality agreements to protect their know-how, technology, data and other
proprietary information and to maintain a competitive position. Trade secrets and know-how can be difficult to protect. Renovaro
Cube and BioSymetrics expect trade secrets and know-how to, over time, be disseminated within the industry through independent
development, the publication of journal articles describing the methodology and the movement of personnel from academic to industry scientific
positions.

Renovaro
Cube and BioSymetrics each seeks to protect these trade secrets and other proprietary technology, in part, by entering into non-disclosure and
confidentiality agreements with parties who have access to them, such as Renovaro Cube’s and BioSymetrics’ employees, directors,
corporate collaborators, outside scientific collaborators, contract research